Related Experiment Video
Updated: Jul 1, 2026

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Association Between Albumin-Corrected Anion Gap and Mortality in ICU Patients With Acute Heart Failure: A MIMIC-IV
Huijuan Pu1, Guoping Zhao1, Yumin Wang2
1Department of General Practice, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China, xzmc.edu.cn.
Insights
Albumin-corrected anion gap (ACAG) is linked to increased mortality in acute heart failure (AHF) patients. Higher ACAG levels indicate a greater risk of death, suggesting ACAG as a potential prognostic tool for AHF.
Area of Science:
- Critical Care Medicine
- Cardiology
- Biochemistry
Background:
- The prognostic significance of albumin-corrected anion gap (ACAG) in acute heart failure (AHF) patients is not well-established.
- Previous studies suggest ACAG is associated with adverse outcomes in critically ill individuals.
Purpose of the Study:
- To investigate the association between ACAG levels and all-cause mortality in patients with AHF.
- To determine if ACAG can serve as a prognostic marker in AHF.
Main Methods:
- Retrospective analysis of 2754 AHF patients from the MIMIC-IV database.
- Patients categorized into tertiles based on ACAG levels.
- Kaplan-Meier survival analysis, Cox proportional hazards models, and restricted cubic spline analyses were used to assess mortality risks at 30, 90, 180, and 365 days.
Main Results:
- Elevated ACAG levels significantly correlated with increased 30- and 365-day all-cause mortality (log-rank p < 0.001).
- The highest ACAG tertile (T3) showed a higher mortality risk compared to the lowest (T1).
- A nonlinear relationship was observed; each 1-unit increase in ACAG above certain thresholds was associated with a 9% increase in 30-day mortality risk (HR 1.09) and an 8% increase in 365-day mortality risk (HR 1.08).
Conclusions:
- Albumin-corrected anion gap is significantly associated with all-cause mortality in AHF patients.
- ACAG demonstrates potential as a valuable prognostic biomarker for predicting outcomes in AHF.
Background:
The albumin-corrected anion gap (ACAG) has been associated with adverse outcomes in critically ill patients. However, its prognostic value in patients with acute heart failure (AHF) remains unclear. This study is aimed at investigating the association between ACAG levels and all-cause mortality in AHF patients.
Methods:
This retrospective study included AHF patients admitted to the intensive care unit (ICU) for the first time, utilizing data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Patients were stratified into tertiles (T1-T3) based on ACAG levels. The primary endpoints were 30- and 365-day all-cause mortality, whereas the secondary endpoints included 90- and 180-day all-cause mortality. Kaplan-Meier (K-M) survival analyses, Cox proportional hazards models, and restricted cubic spline (RCS) analyses were employed to assess the association between ACAG and all-cause mortality.
Results:
A total of 2754 patients were included, with a mean age of 74 years, and 56.5% of the participants were male. K-M curves demonstrated that elevated ACAG levels correlated with increased mortality at 30, 90, 180, and 365 days (all log-rank p < 0.001). Cox regression analysis indicated that T3 was associated with a higher risk of mortality compared with T1. RCS analysis revealed a nonlinear relationship between ACAG and all-cause mortality. Above certain thresholds, each 1-unit increase in ACAG was linked to a 9% increase in the risk of 30-day mortality (hazard ratio [HR] 1.09, 95% confidence interval [CI] 1.07-1.11) and an 8% increase in the risk of 365-day mortality (HR 1.08, 95% CI 1.06-1.09).
Conclusion:
ACAG levels were associated with all-cause mortality in patients with AHF. Thus, ACAG may serve as a valuable prognostic marker for this patient population.
More Related Videos
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management